Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
UFT and Radiotherapy for Rectal Cancer
NCT00207831Phase 3Terminated
- Sponsor
- Institut Cancérologique de l'Ouest
- Start
- Jul 2004
- Primary completion
- Jun 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial of tegafur + uracil in rectal cancer (2 arms), sponsored by Institut Cancérologique de l'Ouest. Primary endpoint: pathologic complete response. Started Jul 2004; status: terminated.
02
Drugs
tegafur + uracil
03
Conditions
rectal cancer
Beyond the preview
Go deeper on NCT00207831.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00207831.